Sign in

Rapport Therapeutics, Inc.

Dec-25 Dec-24 Dec-23 Dec-22
Total revenue 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00
Total operating expenses + 0.13 0.08 0.04 0.01
Operating income -0.13 -0.08 -0.04 -0.01
Non-operating income (net) 0.01 0.00 0.00 0.00
Income before tax -0.11 -0.08 -0.03 -0.01
Income tax expense 0.00
Net income -0.11 -0.08 -0.03 -0.01
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23
Total revenue 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.04 0.04 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01
Operating income -0.02 -0.04 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00
Income before tax -0.02 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01
Income tax expense 0.00 0.00 0.00 0.00
Net income -0.02 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22
Total cash and short-term investments + 0.49 0.31 0.15 0.03
Other current assets 0.01 0.00 0.00 0.00
Total current assets 0.50 0.31 0.15 0.03
Total non-current assets + 0.01 0.01 0.00 0.00
Total assets 0.51 0.31 0.16 0.03
Total current liabilities + 0.02 0.01 0.01 0.00
Total non-current liabilities + 0.01 0.00 0.17 0.01
Total liabilities 0.03 0.01 0.18 0.01
Total stockholders' equity + 0.48 0.31 -0.03 0.02
Common shares outstanding 47 21 18 20
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23
Total cash and short-term investments + 0.48 0.49 0.51 0.26 0.29 0.31 0.32 0.34 0.19 0.15 0.00 0.00 0.00
Accounts receivable, net 0.00
Other current assets 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.01 0.00
Total current assets 0.48 0.50 0.52 0.27 0.29 0.31 0.33 0.34 0.20 0.15
Total non-current assets + 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.00
Total assets 0.50 0.51 0.54 0.29 0.30 0.31 0.33 0.35 0.21 0.16
Total current liabilities + 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Total non-current liabilities + 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.24 0.17
Total liabilities 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.25 0.18
Total stockholders' equity + 0.47 0.48 0.51 0.26 0.29 0.31 0.32 0.34 -0.04 -0.03
Common shares outstanding 47 47 38 35 19 19 19 20 19 18 19 20 19
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22
Operating cash flow + -0.09 -0.06 -0.03 0.00
Cash flow from investing + -0.19 -0.17 -0.08 -0.01
Cash flow from financing + 0.27 0.22 0.15 0.04
Change in cash 0.00 -0.01 0.04 0.03
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23
Operating cash flow + -0.01 -0.02 -0.02 -0.03 -0.02 -0.01 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 0.00
Cash flow from investing + 0.04 -0.17 -0.06 0.02 0.02 0.03 -0.05 -0.11 -0.04 -0.08 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.27 0.00 0.00 0.00 0.00 0.16 0.06 0.00 0.09 0.00 0.06
Change in cash 0.03 -0.20 0.20 0.00 0.00 0.02 -0.07 0.04 0.00 -0.09 0.08 -0.01 0.06
4 days ago

Rapport Therapeutics, Inc. (RAPP) - Costof Goods And Services Sold

1Y 2Y 5Y Max
9 days ago

Rapport Therapeutics, Inc. (RAPP) - Cost Of Revenue

1Y 2Y 5Y Max
9 days ago

Rapport Therapeutics, Inc. (RAPP) - Total Revenue

1Y 2Y 5Y Max
9 days ago

Rapport Therapeutics, Inc. (RAPP) - Gross Profit

1Y 2Y 5Y Max
9 days ago

Rapport Therapeutics, Inc. (RAPP) - Income Tax Expense

1Y 2Y 5Y Max
9 days ago

Rapport Therapeutics, Inc. (RAPP) - Interest Expense

1Y 2Y 5Y Max
9 days ago

Rapport Therapeutics, Inc. (RAPP) - Net Income

1Y 2Y 5Y Max
9 days ago

Rapport Therapeutics, Inc. (RAPP) - Ebitda

1Y 2Y 5Y Max
9 days ago

Rapport Therapeutics, Inc. (RAPP) - Ebit

1Y 2Y 5Y Max
9 days ago

Rapport Therapeutics, Inc. (RAPP) - Net Income From Continuing Operations

1Y 2Y 5Y Max
9 days ago